CASSAVA SCIENCES INC's ticker is SAVA and the CUSIP is 14817C107. A total of 144 filers reported holding CASSAVA SCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $228,000 | -58.5% | 5,445 | -63.2% | 0.25% | -45.6% |
| Q1 2022 | $550,000 | -29.7% | 14,806 | -17.2% | 0.45% | -28.1% |
| Q4 2021 | $782,000 | -62.4% | 17,887 | -46.6% | 0.63% | -61.2% |
| Q3 2021 | $2,080,000 | +212.8% | 33,507 | +330.3% | 1.62% | +218.5% |
| Q2 2021 | $665,000 | +194.2% | 7,786 | +55.1% | 0.51% | +161.0% |
| Q1 2021 | $226,000 | +109.3% | 5,021 | -68.4% | 0.20% | +95.0% |
| Q4 2020 | $108,000 | – | 15,879 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,739,540 | $7,150,000 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 615,000 | $2,528,000 | 0.32% |
| Worth Venture Partners, LLC | 48,535 | $200,000 | 0.12% |
| Ikarian Capital, LLC | 300,000 | $1,233,000 | 0.09% |
| Orbimed Advisors | 250,000 | $1,530,000 | 0.03% |
| Quinn Opportunity Partners LLC | 35,687 | $147,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 38,356 | $158,000 | 0.01% |
| Jefferies Group LLC | 80,000 | $329,000 | 0.00% |
| ClariVest Asset Management LLC | 33,403 | $137,000 | 0.00% |
| Renaissance Technologies | 653,759 | $2,687,000 | 0.00% |